Latest Inhaler Stories
According to the new report from BCC Research, the asthmatic treatment device market is forecast to grow at a compound annual growth rate (CAGR) of 8.9% between 2013 and 2019.
LONDON and SAN FRANCISCO, April 30, 2015 /PRNewswire/ -- GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc.
LONDON, March 24, 2015 /PRNewswire/ -- Key Findings--Chronic obstructive pulmonary disorder (COPD) is the third leading cause of death in the United States, and is in fourth
RICHMOND, Va., March 16, 2015 /PRNewswire/ -- On Friday, the FDA listed Kitabis(TM) Pak as a therapeutic equivalent of TOBI(®) (tobramycin inhalation solution, USP) in their Orange
MUMBAI and BALTIMORE, USA, February 18, 2015 /PRNewswire/ -- Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc.
RICHMOND, Va., Feb. 11, 2015 /PRNewswire/ -- The first patient has been enrolled in the PARI PROVIDE compressor access program to accompany the launch of Kitabis Pak.
- Divestiture permits Actavis to enhance focus on core strategic therapeutic categories - DUBLIN, Feb.
Topical market research report “PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023” elaborated by GlobalData has been recently published at MarketPublishers.com.
Seventy-eight cardiovascular and pulmonary rehabilitation professionals completed a survey about treatments for breathing disorders.
- The parings of haberdine; also, any kind of fragments.
More Images (2 images) »